Molecular monitoring of <scp>MDS</scp>: Watch this space!-Reference-Cited by-同舟云学术

Molecular monitoring of MDS: Watch this space!

Published:2024-07-22 Issue: Volume: Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Scheid Christof¹^ORCID

Affiliation:

1. University of Cologne Cologne Germany

Abstract

The use of IPSS‐M provides a wealth of molecular information in newly diagnosed myelodysplastic syndromes (MDS) patients. Besides the prognostic implications, molecular markers will also help to choose therapeutic options and may also be informative to determine the depth of response. Duployez and Preudhomme provide a comprehensive overview of this area of research, which is particularly complex in MDS.Commentary on: Duployez et al. Monitoring molecular changes in the management of myelodysplastic syndromes. Br J Haematol 2024 (Online ahead of print). doi: 10.1111/bjh.19614.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.19644

Reference5 articles.

1. Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

2. Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape

3. Final phase 1 substudy results of ivosidenib for patients with mutant IDH1 relapsed/refractory myelodysplastic syndrome

4. Ivosidenib monotherapy in IDH1 mutated myelodysplastic syndrome, final results of the IDIOME trial, a GFM study;Sébert M;HemaSphere,2024

5. Monitoring molecular changes in the management of myelodysplastic syndromes

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular monitoring of myelodysplastic neoplasm: Don't just watch this space, consider the patient's ancestry;British Journal of Haematology;2024-08-13